Xiamen Kang Zhongyuan Biotechnology Co., Ltd.: FDA regulatory signals

This page aggregates the United States FDA regulatory records that reference Xiamen Kang Zhongyuan Biotechnology Co., Ltd. in the datasets indexed by this site. Across the ingested data, Xiamen Kang Zhongyuan Biotechnology Co., Ltd. is associated with 15 recall record(s), 0 drug-shortage record(s), and 0 approval record(s). The most recent dated event attributed to this firm in the indexed data is a recall record dated 2026-04-22. These counts are coverage-limited activity signals derived only from the specific FDA datasets indexed here. They are NOT quality ratings, reputational scores, or judgements about the firm or its products. A higher or lower count reflects how often a firm appears in these particular public records over the ingested window — nothing more. Recalls and shortages are routine parts of pharmaceutical regulation, and their presence here is an administrative fact, not an indication of wrongdoing or of product danger. Use this page as a finding aid to locate the underlying FDA records, then verify every detail against the official source. This page contains regulatory information only and offers no medical advice.